Cantel Medical Corp. (NYSE:CMD) has received a consensus broker rating score of 2.25 (Buy) from the four brokers that cover the stock, Zacks Investment Research reports. Two research analysts have rated the stock with a hold recommendation, one has assigned a buy recommendation and one has given a strong buy recommendation to the company. Cantel Medical’s rating score has declined by 12.5% in the last three months as a result of various analysts’ upgrades and downgrades.
Analysts have set a 12 month consensus target price of $114.00 for the company and are expecting that the company will post $0.62 EPS for the current quarter, according to Zacks. Zacks has also given Cantel Medical an industry rank of 93 out of 256 based on the ratings given to its competitors.
A number of analysts recently weighed in on the stock. Sidoti decreased their target price on shares of Cantel Medical from $142.00 to $120.00 and set a “buy” rating on the stock in a report on Friday, September 28th. Raymond James decreased their target price on shares of Cantel Medical from $115.00 to $108.00 and set an “outperform” rating on the stock in a report on Friday, September 28th. Finally, ValuEngine lowered shares of Cantel Medical from a “buy” rating to a “hold” rating in a report on Friday, September 28th.
Cantel Medical (NYSE:CMD) last posted its earnings results on Thursday, November 29th. The company reported $0.62 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.60 by $0.02. The business had revenue of $225.59 million for the quarter, compared to analyst estimates of $227.70 million. Cantel Medical had a net margin of 9.87% and a return on equity of 16.73%. Research analysts expect that Cantel Medical will post 2.6 EPS for the current year.
The business also recently declared a Semi-Annual dividend, which will be paid on Thursday, January 31st. Stockholders of record on Thursday, January 17th will be issued a $0.10 dividend. This is a positive change from Cantel Medical’s previous Semi-Annual dividend of $0.09. The ex-dividend date is Wednesday, January 16th. Cantel Medical’s dividend payout ratio is presently 6.77%.
About Cantel Medical
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.
Featured Article: What is Cost of Capital?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.